Elena
18 Apr, 2006
New York City
Stocks traded higher on strong corporate earnings and economic data which showed that U.S. producer prices climbed 0.5% in March, but core-PPI, excluding food and energy, only rose 0.1%. D.R. Horton reported that Q2 net income advanced 20% on 25% revenue growth. UnitedHealth Group posted Q1 income rise of 21% on 54% higher revenue, missing analyst estimate by a penny. Johnson & Johnson posted Q1 profit rise of 16%, helped byhigher sales of medical devices and a break-up fee.
Elena
18 Apr, 2006
New York City
Stocks opened in the positive, lifted by strong corporate earnings and economic data which showed that U.S. producer prices climbed 0.5% in March, hurt by rising energy prices, but core-PPI, excluding food and energy, only rose 0.1%. D.R. Horton, homebuilder, reported that Q2 net income advanced 20% on 25% revenue growth. UnitedHealth Group reported that Q1 net income went up 21% to 63 cents a share on 54% higher revenue, missing analyst estimate by a penny.
Elena
18 Apr, 2006
New York City
Merrill Lynch & Co. reported sharply lower Q1 earnings due to a hefty charge for the expenses for stock-based compensation. The company posted 44 cents per share vs. $1.22 a share last year, still beating analyst expectations. D.R. Horton, homebuilder, reported that Q2 net income advanced 20% on 25% revenue growth.
Elena
18 Apr, 2006
Mumbai
Sensex in India scaled more than 2% advance for the second day in a row after the Reserve Bank of India left the interest rates unchanged. Prime Minister indicated that annual GDP growth of 10% is a realistic target. Strong earnings from software giant TCS propelled IT stocks. Banking and cement stocks rose for the second day in a row.
Elena
18 Apr, 2006
Frankfurt
European stocks traded mixed at mid-day after the long holiday weekend. Stocks were dragged by surging commodities prices and disappointing earnings from Philips Electronics. The German DAX 30 dropped 0.6%, the French CAC 40 edged down 0.2%, while London FTSE 100 climbed 0.4%, supported by gains in oil and mining companies.
Elena
18 Apr, 2006
New York City
Asian markets closed higher with the Nikkei in the lead. The Japanese index was boosted by strength in financial, brokerage and commodities-related stocks. Australia All Ordinaries rose 1.3% helped by mining stocks like BHP Billioton. Hong Kong Hang Seng climbed 0.9% with China Mobile rising 3.4% and Synopec surging 4.3%.
123jump.com Staff
17 Apr, 2006
Metals
Market averages closed lower as earnings from banks dominted the calendar. Oil above $70 and gold, silver and copper at a new high took a bite out of the market mild climb in the morning. Wachovia, Citigroup and SunTrust reported earnings that met expectations. Gardner Denver raised earnings outlook. Goldman to underwrite $2.45 billion MasterCard IPO. India, Russia and Mexico lead rise in emerging markets.
123jump.com Staff
17 Apr, 2006
New York City
Markets in emerging markets rose on strong advances in India, Russia, Taiwan and Mexcio. Taiwan Index crossed for the first time 7,000 mark. Infosys and local cement companies earnings supporte gains in Indian market. Brazil advanced on gains in iron ore and metal price rise. Copper price rise supported stocks in Mexico.Shanghai continued to rise ahead of Chinese President visit.
123jump.com Staff
17 Apr, 2006
Metals
In the early afternoon market averages are trading at their lowest level for the day. Oil climbs above $70 and gold is up $15. Three major averages are down close to 0.5% and Nasdaq down 1%. Transportation companies report better than expected earnings but large bank report weak earnings gain. Ailine stocks are down on higher cost of oil.
Elena
17 Apr, 2006
New York City
Stocks traded little echanged as surging oil prices limited gains. Citigroup, the largest U.S. bank reported Q1 profit rise of 4% on revenue growth from foreign operations. Elsewhere in the bank sector, Wachovia said that its Q1 net income advanced 7% to $1.09 a share, but missed estimates of $1.12 a share. Charles Schwab Corp. posted 68% jump in Q1 income on record revenue. Knight Ridder reported Q1 profit decrease of 42 cents a share from 79 cents last year, despite revenue increase.
Elena
17 Apr, 2006
Mumbai
Sensex recovered the loss of the prior week on strong earnings from Infosys and Gujarat Ambuja and HDFC Bank. The Reserve Bank of India is likely to hike interest rate in tomorrow policy announcement. Metals, tech and banking sectors rallied on a lower than average daily turnover.
Elena
17 Apr, 2006
New York City
Stocks opened above the flat line, supported by strong earnings report from Citigroup. The largest U.S. bank reported Q1 profit rise of 4% on revenue growth from foreign operations. Elsewhere in the bank sector, Wachovia said that its Q1 net income advanced 7% to $1.09 a share, but missed estimates of $1.12 a share. Charles Schwab Corp. posted 68% jump in Q1 income on record revenue. Knight Ridder reported Q1 profit decrease of 42 cents a share from 79 cents last year, despite revenue increase.
Elena
17 Apr, 2006
New York City
Stock futures predicted a slightly positive start, reflecting strong earnings report from Citigroup. The largest U.S. bank reported Q1 profit rise of 4% on revenue growth from foreign operations. In other earnings news, Wachovia Corp. said that its Q1 net income advanced to $1.09 a share, up from $1.01 a share a year earlier, but missed estimates of $1.12 a share. Knight Ridder reported Q1 profit decrease of 42 cents a share from 79 cents last year, despite revenue increase.
Elena
17 Apr, 2006
New York City
Asian markets closed mixed with the Nikkei leading decliners on surging oil and gold prices. Weakness among real estate and consmer financial stocks also helped the downward trend to lead the Japanese index down 1.4% ro 17,000.36. South Korean Kospi lost ground after record highs to end lower 0.7% on profit taking. Among gainers, China Shanghai Composite rose 1.4%, followed by Taiwan Weighted index, up 0.7%.
Yordanka
16 Apr, 2006
New York City
Two drug discovery companies'' initial public offerings fell in their first day of trading, as investors avoided higher-risk deals. Biopharmaceutical companies Targacept and Vanda Pharmaceuticals both priced $2 below their expected ranges, and then went lower.
